Mr David L Ozimek, PA-C | |
140 Hazard Ave, Suite 101, Enfield, CT 06082-4520 | |
(860) 763-7668 | |
(860) 763-7676 |
Full Name | Mr David L Ozimek |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 140 Hazard Ave, Enfield, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528399763 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 000245 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr David L Ozimek, PA-C 140 Hazard Ave, Suite 101, Enfield, CT 06082-4520 Ph: (860) 763-7668 | Mr David L Ozimek, PA-C 140 Hazard Ave, Suite 101, Enfield, CT 06082-4520 Ph: (860) 763-7668 |
News Archive
After a decade of research, Zapne LLC has released its signature acne treatment, Zapne, an all-natural product to treat acne without the harsh side effects of many current regimens. Zapne offers four key advantages over most acne treatments: The treatment system is formulated from natural, non-synthetic ingredients, produces no material side effects, requires only a single 15-minute weekly application, and produces visible results quickly, in some cases after only one or a few applications.
For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC).
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
Atrial fibrillation is the most common heart rhythm disorder in the U.S., affecting more than 2 million adults. The prevalence of the condition is rising and scientists predict that about 5.6 million Americans will have the disorder by 2050. Known causes of AF include abnormalities in the heart's structure and long-term uncontrolled high blood pressure.
Flexpoint Sensor Systems, Inc., http://www.flexpoint.com, announced that they are currently working under an agreement with a company on the development of a Home Monitoring Presence Detection System using their patented Bend SensorĀ® design.
› Verified 9 days ago
Mrs. Melissa D'amato, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 140 Hazard Ave Ste 105, Enfield, CT 06082 Phone: 860-714-9733 Fax: 860-714-8136 | |
Mrs. Lori Ann Bryon, PA C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 170 Hazard Ave, Enfield, CT 06082 Phone: 860-749-2022 | |
Madeline Murphy, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 170 Hazard Ave, Enfield, CT 06082 Phone: 860-749-2022 Fax: 860-763-1398 | |
Julie M Wondolowski, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 701 Enfield St, Enfield, CT 06082 Phone: 860-741-6058 Fax: 860-741-6864 | |
Kaitlin G. Pulito, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 701 Enfield Street, Enfield, CT 06082 Phone: 860-741-6058 Fax: 860-741-6864 | |
Mrs. Melanie Jean Koumentakos, PA C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 113 Elm St, Suite 304, Enfield, CT 06082 Phone: 860-741-2225 Fax: 860-741-2229 | |
Lawrence S. Benjamin, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 875 Enfield St, Enfield, CT 06082 Phone: 860-741-3014 |